Category - Pharma Leaders
Expanding Immune Response Testing to Support Vaccine Development
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
How to Overcome Market Access Hurdles for Inpatient Drug Launches
Johnson & Johnson’s Novel Intravesical Gemcitabine Shows Durable Response in BCG-Unresponsive Bladder Cancer
Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia
How Tariffs Might Impact Drug Pricing and Access
Sebela’s Novel Potassium-Competitive Acid Blocker Demonstrates Promise in Gastroesophageal Reflux Disease
Making Real-World Evidence Work for Medicare: What CMS’ Draft Guidance Gets Right and What Needs Work